Taiwanese company 'BluSense Diagnostics' have developed a Zika detecting machine that would cost $20 per patient.
The 'BluBox' takes a blood sample and within nine minutes a diagnosis is ready. The machine only needs a drop of blood for it's sample which is mixed with magnetic nanoparticles before it is scanned by the machine's internal laser. This is a viable solution to an existing medical issue as Zika detection tests currently cost patients hundreds of dollars to preform. At $20 a patient, the BluBlox is a viable global detection method.
The BluBox Zika detection machine also includes an automated data reporting system that sends positive test results to a database so every case of the virus can be monitored.
Why This Trend Is Growing
- Affordable Disease Testing
- The development of inexpensive disease detection technology presents an opportunity to disrupt healthcare industries and promote accessible medical testing globally.
- Advanced Data Reporting
- Automation and advanced data collection methods can enhance disease monitoring and response capabilities, creating opportunities for innovation in healthcare management.
- Nanoparticle Technology
- Nanoparticle technology can be utilized to create more efficient disease testing methods and has the potential to revolutionize many industries, including medicine.
Industries Being Reshaped
- Healthcare
- Affordable disease testing solutions present opportunities for companies in the healthcare industry to expand access to medical testing and improve patient outcomes.
- Data Management
- Automation and advanced data collection methods in disease monitoring can create opportunities for data management industries to provide innovative solutions for healthcare providers.
- Nanotechnology
- The development of disease testing machines utilizing magnetic nanoparticle technology presents opportunities for innovation in the field of nanotechnology and its applications in many industries.
